Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJ5LT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $94,497
Award facts
- Contract value 100% obligated
- $94,496.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, with a ceiling value of $94,496.98 for the supply of RINVOQ ER 30 mg tablets in units of 30 tablets. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and was competitively awarded without a set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA encompasses a broad range of therapeutic medications, including specialty drugs, brand-name and generic pharmaceuticals, and related medical supplies. This specific delivery order for RINVOQ ER tablets represents a routine pharmaceutical supply transaction within the company's comprehensive global pharmaceutical support vehicle for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DB25FJ5LT?
SPE2DB25FJ5LT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FJ5LT worth?
The government has obligated $94,497 on SPE2DB25FJ5LT.
Is contract SPE2DB25FJ5LT an order under another contract?
Yes. SPE2DB25FJ5LT is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5LT competed?
The extent of competition for SPE2DB25FJ5LT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award